Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Date Time Source Announcement
01 Mar 2021 9:36 am
RNS
Total Voting Rights
26 Feb 2021 10:46 am
RNS
PDMR Dealings / Market Share sale
05 Feb 2021 1:22 pm
RNS
Holdings in Company
03 Feb 2021 7:00 am
RNS
Board Changes
01 Feb 2021 9:47 am
RNS
Total Voting Rights
18 Jan 2021 4:34 pm
RNS
Prime Minister Boris Johnson formally opens Oxbox
04 Jan 2021 2:09 pm
RNS
Block Listing Return
  1:41 pm
RNS
Total Voting Rights
30 Dec 2020 9:03 am
RNS
OXB notes AZ vaccine has been authorised in the UK
01 Dec 2020 12:17 pm
RNS
Director Dealings
  9:02 am
RNS
Total Voting Rights
23 Nov 2020 8:47 am
RNS
OXB notes AZD1222 met primary efficacy endpoint
  7:00 am
RNS
Non-Executive Director Appointment
09 Nov 2020 7:00 am
RNS
OXB and PhoreMost enter gene therapy collaboration
02 Nov 2020 9:02 am
RNS
Total Voting Rights
30 Oct 2020 7:00 am
RNS
Axovant update on AXO-Lenti-PD and virtual R&D day
23 Oct 2020 10:27 am
RNS
Director Purchase
12 Oct 2020 5:38 pm
RNS
Holding(s) in Company
06 Oct 2020 12:46 pm
RNS
Axovant update on 2nd cohort of SUNRISE-PD trial
  7:00 am
RNS
OXB receives approval for fourth suite in Oxbox
05 Oct 2020 10:59 am
EQS
Oxford Biomedica (OXB): Vector innovation key to cell and gene evolution
02 Oct 2020 11:52 am
RNS
Total Voting Rights
29 Sep 2020 3:51 pm
RNS
Director Dealings
24 Sep 2020 9:36 am
RNS
Director/PDMR Shareholding
22 Sep 2020 12:54 pm
RNS
Director/PDMR Shareholding
17 Sep 2020 7:00 am
RNS
Interim Results
01 Sep 2020 9:33 am
RNS
Total Voting Rights
  7:00 am
RNS
Master Supply and Development Agreement with AZ
27 Aug 2020 7:00 am
RNS
Notice of Interim Results
25 Aug 2020 4:46 pm
RNS
Block listing Application
03 Aug 2020 9:41 am
RNS
Total Voting Rights
  7:00 am
RNS
OXB signs DMLA with Beam Therapeutics
31 Jul 2020 7:00 am
RNS
OXB Signs Clinical Supply Agreement with Axovant
20 Jul 2020 4:23 pm
RNS
OXB notes interim results from AZ on AZD1222
03 Jul 2020 10:45 am
RNS
Director Dealings / Market Share Purchase
02 Jul 2020 3:39 pm
RNS
Director Dealings / Market Share Purchase
  1:34 pm
RNS
Director Dealings / Market Share Transactions
01 Jul 2020 6:30 pm
RNS
Holdings in Company
  3:44 pm
RNS
Block listing Return
  9:13 am
RNS
Total Voting Rights
30 Jun 2020 3:23 pm
RNS
Grant of options
25 Jun 2020 9:44 am
RNS
Holding(s) in Company
24 Jun 2020 11:45 am
RNS
Holdings in Company
  9:54 am
RNS
Director Dealings / Share Disposal - Replacement
23 Jun 2020 4:46 pm
RNS
Result of Annual General Meeting
  2:47 pm
RNS
Admission of shares and Total Voting Rights.
  7:00 am
RNS
Annual General Meeting
19 Jun 2020 3:26 pm
RNS
Information in Relation to Annual General Meeting
  7:00 am
RNS
Result of Placing
18 Jun 2020 5:33 pm
RNS
Proposed Placing of new Ordinary Shares
08 Jun 2020 4:01 pm
RNS
Update on Sanofi Ophthalmology Programmes
  7:00 am
RNS
Five Year Collaboration Agreement signed with VMIC
01 Jun 2020 9:06 am
RNS
Total Voting Rights
  7:00 am
RNS
Dr Roch Doliveux appointed Non-Executive Chairman
28 May 2020 12:16 pm
RNS
Clinical & Commercial Supply Agreement with AZ
27 May 2020 11:26 am
RNS
Director Dealings / Market Share Purchase
22 May 2020 5:28 pm
RNS
2019 Annual report and Accounts & AGM Notification
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t